United States Senators Urge DOJ and FDA for E-cigarette Enforcement

Regulations by 2FIRSTS.ai
Jul.09.2024
United States Senators Urge DOJ and FDA for E-cigarette Enforcement
Senators Demand More Information on Crackdown on Unauthorized E-Cigarette Sales by Multi-Agency Task Force, Expressing Concerns Over Inconsistencies in Statements.

According to a report from the Sierra Sun Times on July 8th, last week, US Senator Susan Collins and her bipartisan colleagues wrote to senior officials at the Department of Justice (DOJ) Consumer Protection Division and the US Food and Drug Administration (FDA) Center for Tobacco Products, requesting more information about the recently announced interagency task force to combat unauthorized e-cigarette sales and distribution.

 

The letter also reiterated the importance of restoring the pre-market review process required by federal law. The letter was co-signed by Senators Dick Durbin (D-IL), Mitt Romney (R-UT), Richard Blumenthal (D-CT), Jeff Merkley (D-OR), Thom Tillis (R-NC), Mazie Hirono (D-HI), and Ron Wyden (D-OR).

 

The senators wrote,

 

We appreciate the recent announcement of the establishment of a federal task force to enhance enforcement of these illegal and dangerous products through the collaboration of the FDA, Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Marshals Service, U.S. Postal Inspection Service, and Federal Trade Commission. However, we remain deeply concerned about the inconsistency between the public statements of the FDA and DOJ, which claim that only 27 e-cigarette products have been authorized by the FDA, while in fact, thousands of unauthorized e-cigarettes with child-friendly flavors such as blueberry ice, strawberry watermelon bubblegum, and Red Bull strawberry are still readily available.

 

Clearly, the top priority of the working group should be to restore the pre-market review system for e-cigarettes and enforce the removal of all unauthorized e-cigarettes.

 

On June 10, 2024, the United States Department of Justice and the Food and Drug Administration announced the establishment of a federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes. In addition to the FDA and the DOJ, this task force will also bring together multiple law enforcement agencies, utilizing all criminal and civil measures to crack down on illegal e-cigarette distribution and sale.

 

This letter also calls on the FDA to complete long-term reviews of premarket tobacco product applications submitted by e-cigarette manufacturers. Since the FDA missed the final deadline set by the court on September 9, 2021, over 2.1 million children may have already started using e-cigarettes. The FDA also missed another deadline to complete reviews of certain products by June 30, 2024. According to the Tobacco Control Act (TCA), e-cigarette companies must obtain FDA authorization before entering the market, a requirement that the FDA has failed to enforce.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Malaysian police raids across five states: 51 held and over RM1 million in vapes seized
Malaysian police raids across five states: 51 held and over RM1 million in vapes seized
Police in Malaysia detained 51 individuals and seized over RM1 million worth of electronic cigarettes and liquid refills in a five-state operation dubbed “Op E-CIG,” conducted by the GOF Central Brigade on February 10. The report said the operation involved 30 raids across Kuala Lumpur, Johor, Melaka, Selangor and Negeri Sembilan. Authorities seized 2,263 vape units and 165.463 litres of liquid.
Feb.12 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G said it plans to cancel all treasury shares it holds, totaling 10,866,189 shares, representing about 9.5% of shares outstanding, in line with Korea’s third amendment to the Commercial Act requiring companies to cancel repurchased shares within one year. The company also disclosed progress on its shareholder-return plan and multiple agenda items for next month’s shareholders meeting.
Feb.26